Biblio
CD38-directed, single-chain T cell-engager targets leukemia stem cells through IFNγ-induced CD38 expression. Blood. 2024.
HDAC4 inhibition disrupts TET2 function in high-risk MDS and AML. Aging (Albany NY). 2020;12.
Identification of a novel NPM1 mutation in acute myeloid leukemia. Exp Hematol Oncol. 2023;12(1):87.
.